Evidence map›Paper›PMID 42304137›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathy.

Tim L T Wiegand, Anna Rubinski, Leonard B Jung, Nicolai Franzmeier, Hector Arciniega, Parsa Ravanfar, Anna Dewenter, Michael L Alosco, Yorghos Tripodis, Yi Su and 16 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Tim L T WiegandPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Anna RubinskiInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Leonard B JungPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Nicolai FranzmeierInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Hector ArciniegaDepartment of Rehabilitation Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Parsa RavanfarPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Anna DewenterInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Michael L AloscoAlzheimer's Disease Research Center and CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Yorghos TripodisAlzheimer's Disease Research Center and CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Yi SuBanner Alzheimer's Institute, Phoenix, Arizona, USA.
Hillary ProtasBanner Alzheimer's Institute, Phoenix, Arizona, USA.
Alexander P LinPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Ofer PasternakPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Kewei ChenBanner Alzheimer's Institute, Phoenix, Arizona, USA.
Michael J ColemanPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Sylvain BouixPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Charles H AdlerDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Laura J BalcerDepartment of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
Charles BernickLou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, Nevada, USA.
Jeffrey L CummingsChambers-Grundy Center for Transformative Neuroscience Department of Brain Health, Kirk Kerkorian School of Medicine, , University of Nevada Las Vegas, Las Vegas, Nevada, USA.
Robert A SternAlzheimer's Disease Research Center and CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Eric M ReimanBanner Alzheimer's Institute, Phoenix, Arizona, USA.
Martha E ShentonPsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.
Michael EwersInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Inga K KoertePsychiatry Neuroimaging Laboratory, Psychiatry Department, Mass General Brigham Academic Medical Centers, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-1281-9286
DIAGNOSE CTE Research Project

Funding

Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI Robert J. Fox, Jefferson Kinney · 2015 to 2026
$22.8M
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project IIR01NS139383 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Michael Alosco, Nicholas Ashton · 2024 to 2026
$9.3M
Understanding the Cognitive and Neural Consequences of Repetitive Head ImpactsK00NS113419 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI ARCINIEGA, HECTOR · 2020 to 2022
$265k
Alzheimer's Disease Drug Discovery Foundation (ADDF)Black Men's Brain Health Emerging Scholars FellowshipBundes Ministerium für Bildung und ForschungBurroughs Wellcome Fund Postdoctoral Diversity Enrichment ProgramClinical Sciences Research and Development Merit Award I01-CX001038Grass Foundations Henry GrassHarvard's Mind Brain and Behavior Young Investigator AwardJoy Chambers-Grundy EndowmentM.D. Rising Star in Neuroscience AwardNational Institute of Neurological Disorders and Stroke (NINDS) K23NS102399National Institute of Neurological Disorders and Stroke (NINDS) P30AG019610National Institute of Neurological Disorders and Stroke (NINDS) P30AG072978National Institute of Neurological Disorders and Stroke (NINDS) P30AG072980National Institute of Neurological Disorders and Stroke (NINDS) R01NS078337National Institute of Neurological Disorders and Stroke (NINDS) R01NS100952National Institute of Neurological Disorders and Stroke (NINDS) RF1NS122854National Institute of Neurological Disorders and Stroke (NINDS) U01NS093334National Institute of Neurological Disorders and Stroke (NINDS) U54NS115266NIA NIH HHS R25AG083721-01NIA NIH HHS R35AG71476NIGMS NIH HHS P20GM109025NIMHD NIH HHS L32 MD016519NINDS NIH HHS K00 NS113419NINDS NIH HHS R01NS139383Rainwater Charitable Foundation Tau Leadership Fellows AwardTed and Maria Quirk EndowmentUnited States (U.S.) Department of Veterans Affairs
6 · The paper itself

Abstract

introductionChronic traumatic encephalopathy (CTE) is a tauopathy linked to repetitive head impacts. Factors influencing brain regional susceptibility to tau deposition and spreading remain unclear.

methodsWe used three datasets: [18F]flortaucipir positron emission tomography (PET) in 157 former professional American football players and 53 controls (DIAGNOSE CTE); cortical myelin water fractions (MWF) in 50 healthy individuals (Myelin Water Atlas); and white matter (WM) tract MWF and functional connectivity (FC) in 100 healthy individuals (Human Connectome Project). We tested associations between tau-PET uptake and covariance in football players and typical cortical gray matter (GM) MWF, WM tract MWF, and FC.

resultsCortical regions with lower typical GM MWF showed higher tau-PET uptake (β = -0.399, p = 0.001). WM tracts with lower typical MWF were associated with higher tau-PET covariance (β = -0.238, p < 0.001). Higher typical FC was associated with higher tau-PET covariance (β = 0.447, p < 0.001). DISCUSSION: In former football players at risk for CTE, regional susceptibility to tau deposition may be driven by low myelin and high FC.

Indexed as

BrainChronic Traumatic EncephalopathyTauopathiesAdultDisease SusceptibilityFemaleFootballGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedMyelin SheathPositron-Emission Tomographytau ProteinsWhite Mattertau ProteinsAmerican footballCTEdementiafunctional connectivitymyelin levelsneurodegenerationneuroimagingrepetitive head impactstauopathytau‐PET

Identifiers

PMID42304137
PMCPMC13272103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.